A Case of Dural Arteriovenous Fistula Following Cerebral Venous Sinus Thrombosis Associated with the COVID-19 Vaccine
- PMID: 38260037
- PMCID: PMC10800167
- DOI: 10.5797/jnet.cr.2023-0052
A Case of Dural Arteriovenous Fistula Following Cerebral Venous Sinus Thrombosis Associated with the COVID-19 Vaccine
Abstract
Objective: Cerebral venous sinus thrombosis (CVST) is one of the rare and severe complications of coronavirus disease 2019 (COVID-19) vaccines. CVST has also been reported to develop into dural arteriovenous fistula; however, there were no reports of dural arteriovenous fistula associated with COVID-19 vaccine-induced cerebral venous sinus thrombosis. Here, we describe a rare case of a transverse-sigmoid sinus dural arteriovenous fistula followed by CVST due to COVID-19 vaccination.
Case presentation: A 70-year-old patient presented with headache five days after receiving a second dose of COVID-19 vaccine. MRI showed a CVST in the superior sagittal sinus, left transverse sinus, and left sigmoid sinus. His headache improved after the administration of anticoagulant therapy. Six months later, a similar headache recurred, and cerebral angiography demonstrated a dural arteriovenous fistula in the left transverse sigmoid sinus and convexity dural arteriovenous fistulas in the left parietal cortex. The patient was treated twice with two sessions of transarterial embolization, and the shunts were completely occluded. His symptoms improved, and he was discharged with a modified Rankin Scale score of 0.
Conclusion: Dural arteriovenous fistula can develop after CVST in association with COVID-19 vaccination.
Keywords: COVID-19; cerebral venous sinus thrombosis; dural arteriovenous fistula; vaccine.
©2024 The Japanese Society for Neuroendovascular Therapy.
Figures



Similar articles
-
Cerebral venous sinus thrombosis and dural arteriovenous fistula associated with protein S deficiency: a case series study.BMC Neurol. 2022 May 2;22(1):164. doi: 10.1186/s12883-022-02693-3. BMC Neurol. 2022. PMID: 35501720 Free PMC article.
-
Clinical characteristics and outcome of dural arteriovenous fistulas secondary to cerebral venous sinus thrombosis: a primary or secondary event?BMC Neurol. 2023 Mar 30;23(1):131. doi: 10.1186/s12883-023-03141-6. BMC Neurol. 2023. PMID: 36997877 Free PMC article.
-
Identification of LDLR mutation in cerebral venous sinus thrombosis co-existing with dural arteriovenous fistulas: a case report.BMC Neurol. 2023 Nov 28;23(1):423. doi: 10.1186/s12883-023-03455-5. BMC Neurol. 2023. PMID: 38017368 Free PMC article.
-
[Dural arteriovenous fistula of the transverse sigmoid sinus after transvenous embolization of the carotid cavernous fistula].No To Shinkei. 1999 Dec;51(12):1065-9. No To Shinkei. 1999. PMID: 10654304 Review. Japanese.
-
Multiple Dural and Pial Arteriovenous Fistulae in a Twenty-Four-Year-Old Woman in the Setting of Superior Sagittal Sinus Thrombosis: Case Report and Review of Literature.J Stroke Cerebrovasc Dis. 2016 Oct;25(10):e192-9. doi: 10.1016/j.jstrokecerebrovasdis.2016.07.037. Epub 2016 Aug 17. J Stroke Cerebrovasc Dis. 2016. PMID: 27544867 Review.
References
-
- Rizk JG, Gupta A, Sardar P, et al. Clinical characteristics and pharmacological management of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis: a review. JAMA Cardiol 2021; 6: 1451–1460. - PubMed